Danske Bank
CTSO icon

Danske Bank’s Cytosorbents Corp CTSO Stock Holding History

Danske Bank’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Buy
+1
New +$7 ﹤0.01% 1095

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Danske Bank's CTSO Position: Q3 2026 in Review

Danske Bank opened a new position in Cytosorbents Corp (CTSO) in Q3 2026: 1 share worth $4. The stake represents ﹤0.01% of the portfolio and ranks #1095 among its holdings.

7 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • Danske Bank held 1 share of Cytosorbents Corp worth $4 as of Q3 2026.
  • Cytosorbents Corp was a new Danske Bank position in Q3 2026.
  • Cytosorbents Corp made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1095 holding.
  • 7 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.